Clinical trials
Carcinoma, Medullary trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2011 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 5 |
| Unknown status | 4 |
| Active, not recruiting | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2 |
| Aristotle University Of Thessaloniki | 1 |
| CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 1 |
| Eli Lilly and Company | 1 |
| First Affiliated Hospital of Fujian Medical University | 1 |
| Hoffmann-La Roche | 1 |
| Loxo Oncology, Inc. | 1 |
| Luo Yaping | 1 |
| National Cancer Institute (NCI) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Medullary | 17 |
| Carcinoma, Non-Small-Cell Lung | 4 |
| Thyroid Neoplasms | 3 |
| Neoplasms | 2 |
| Adenocarcinoma | 1 |
| Adenocarcinoma, Papillary | 1 |
| Adenoma, Islet Cell | 1 |
| Adrenocortical Carcinoma | 1 |
| Bronchial Neoplasms | 1 |
| Carcinoma | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.